Project 2: STAT3 as a trigger for T1D
Project 2: STAT3 as a trigger for T1D
批准号:
10328102
负责人:
Mark S Anderson
金额:
$40.38万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-17 至 2027-01-31
关键词:
Adoptive TransferAllelesAnimal ModelAnimalsAntigensAutoantibodiesAutoimmuneAutoimmune DiabetesAutoimmunityB-LymphocytesCD8-Positive T-LymphocytesCell SurvivalCell surfaceCellsClinicalCollaborationsCritical PathwaysDefectDevelopmentDiabetes MellitusDiseaseEngineeringEpithelialFOXP3 geneFamily memberGene ActivationGene ExpressionGenesGeneticGenetic TranscriptionHormonesHumanHuman GeneticsImmuneImmune ToleranceImmune systemInbred NOD MiceInsulinInsulin-Dependent Diabetes MellitusInterleukin-6Knock-in MouseKnowledgeLinkMHC Class II GenesMapsMediatingMendelian disorderMissense MutationModelingMusMutationNatural ImmunityPathway interactionsPatientsPhenotypePhosphorylationPlayPopulationPredispositionRegulatory T-LymphocyteReportingResearch PersonnelRoleSignal TransductionStat2 proteinStat3 proteinStudy modelsSyndromeT-LymphocyteThymic epithelial cellThymus GlandTimeTissuesTranscription Factor 3ValidationVariantWorkadaptive immunitycentral tolerancecytokinecytopeniaexome sequencinggain of function mutationimprovedinsightinsulin dependent diabetes mellitus onsetinsulitisisletlymphadenopathymouse modelnovelperipheral bloodperipheral tolerancesuccesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Monogenic diseases that have a close association with the development of type 1 diabetes have been
informative for unraveling critical pathways that keep this disease in check. Examples of success using this
approach include the study of AIRE and FOXP3 which have been informative for identifying pathways in the
thymus and T regulatory cells that keep type 1 diabetes in check. Here, we will leverage the recent knowledge
that gain of function mutations (GOF) in STAT3 are tightly associated with the development of type 1 diabetes
by developing a robust animal model of the syndrome.
Our specific aims are:
Aim 1: Model the effects of STAT3 GOF in a novel mouse model of autoimmune diabetes
(NOD.STAT3K392R/+)
Aim 2: Identify and characterize key immune cell populations that are defective in the NOD.STAT3K392R/+
model and in patients with similar STAT3 GOF mutations
Aim 3: Identify how central tolerance is potentially altered in STAT3 GOF models
These studies will be performed in close collaboration with PPG projects 1 (Cooper) and 3 (Marson) and will
help improve our understanding of how the immune tolerance is controlled by STAT3 and how alterations in
this molecule can provoke type 1 daibetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10328098
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10576386
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10328097
-
项目类别:
-
资助金额:$176.58万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10630946
-
项目类别:
-
资助金额:$46.85万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10502136
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10328099
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10503923
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10683384
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10576378
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10576375
-
项目类别:
-
资助金额:$176.56万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Administrative Core
-
批准号:10576377
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Immune Tolerance Network
-
批准号:10625931
-
项目类别:
-
资助金额:$684.91万
-
财政年份:2021
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10179371
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10413178
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10020398
-
项目类别:
-
资助金额:$95.13万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10762177
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance
-
批准号:9106605
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Core A - Animal core
-
批准号:9151386
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Project 1 - Central thymic tolerance as a major checkpoint in T1D
-
批准号:9151388
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Disruption of T cell tolerance in type 1 diabetes
-
批准号:9291418
-
项目类别:
-
资助金额:$162.91万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
海外基金